A Requirement for Cyclin-Dependent Kinase 6 in Thymocyte Development and Tumorigenesis

被引：99

作者：

Hu, Miaofen G. ^{[1
]}

Deshpande, Amit ^{[4
]}

Enos, Miriam ^{[1
]}

Mao, Daqin ^{[1
]}

Hinds, Elisabeth A. ^{[1
]}

Hu, Guo-fu ^{[2
]}

Chang, Rui ^{[1
,3
]}

Guo, Zhuyan ^{[1
,5
]}

Dose, Marei ^{[1
,6
]}

Mao, Changchuin ^{[1
]}

Tsichlis, Philip N. ^{[1
]}

Gounari, Fotini ^{[1
,6
]}

Hinds, Philip W. ^{[1
]}

机构：

[1] Tufts Med Ctr, Mol Oncol Res Inst, Boston, MA 02111 USA

[2] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA

[3] Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA

[4] Univ Calif Los Angeles, Dent Res Inst, Los Angeles, CA 90024 USA

[5] MIT, Ctr Canc Res, Dept Biol, Cambridge, MA 02139 USA

[6] Univ Chicago, Dept Med, Comm Immunol, Chicago, IL 60637 USA

来源：

CANCER RESEARCH | 2009年 / 69卷 / 03期

关键词：

T-CELL DEVELOPMENT; SIGNALING PATHWAY; GENE-EXPRESSION; NOTCH; INDUCTION; INSULIN; LINEAGE; CDK6; FATE; SUPPRESSION;

D O I：

10.1158/0008-5472.CAN-08-2473

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Cyclin-dependent kinase 6 (CDK6) promotes cell cycle progression and is overexpressed in human lymphoid malignancies. To determine the role of CDK6 in development and tumorigenesis, we generated and analyzed knockout mice. Cdk6-deficient mice show pronounced thymic atrophy due to reduced proliferative fractions and concomitant transitional blocks in the double-negative stages. Using the OP9-DL1 system to deliver temporally controlled Notch receptor-dependent signaling, we show that CDK6 is required for Notch-dependent survival, proliferation, and differentiation. Furthermore, CDK6-deficient mice were resistant to lympho-magenesis induced by active Akt, a downstream target of Notch signaling. These results show a critical requirement for CDK6 in Notch/Akt-dependent T-cell development and tumorigenesis and strongly support CDK6 as a specific therapeutic target in human lymphoid malignancies. [Cancer Res 2009; 69(3):810-8]

引用

页码：810 / 818

页数：9

共 50 条

[31] Recent advances in the development of cyclin-dependent kinase 7 inhibitors
Teng, Yuou
Lu, Kui
Zhang, Qian
Zhao, Lianbo
Huang, Yuna
Ingarra, Angela Maria
Galons, Herve
Li, Tingshen
Cui, Shanshan
Yu, Peng
Oumata, Nassima
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 183
[32] Chemoprevention of Mouse Intestinal Tumorigenesis by the Cyclin-Dependent Kinase Inhibitor SNS-032
Boquoi, Amelie
Chen, Tina
Enders, Greg H.
CANCER PREVENTION RESEARCH, 2009, 2 (09) : 800 - 806
[33] Flavopiridol, a novel cyclin-dependent kinase inhibitor, in clinical development
Zhai, SP
Senderowicz, AM
Sausville, EA
Figg, WD
ANNALS OF PHARMACOTHERAPY, 2002, 36 (05) : 905 - 911
[34] Cyclin-dependent kinase inhibitors in the development of the central nervous system
Cunningham, JJ
Roussel, MF
CELL GROWTH & DIFFERENTIATION, 2001, 12 (08): : 387 - 396
[35] Function of cyclin-dependent kinase 13 during mouse development
Kohoutek, Jiri
Novakova, Monika
Paculova, Hana
Chawengsaksophak, Kallayanee
Sedlacek, Radislav
TRANSGENIC RESEARCH, 2016, 25 (02) : 242 - 242
[36] Cyclin-dependent kinase 4 expression is essential for neu-induced breast tumorigenesis
Reddy, HKDL
Mettus, RV
Rane, SG
Graña, X
Litvin, J
Reddy, EP
CANCER RESEARCH, 2005, 65 (22) : 10174 - 10178
[37] Cyclin specificity in the phosphorylation of cyclin-dependent kinase substrates
Loog, M
Morgan, DO
NATURE, 2005, 434 (7029) : 104 - 108
[38] Cyclin-Dependent Kinase Inhibition by Flavoalkaloids
Jain, S. K.
Bharate, S. B.
Vishwakarma, R. A.
MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2012, 12 (07) : 632 - 649
[39] Expression of cyclins, cyclin-dependent kinases and cyclin-dependent kinase inhibitors in oligodendrogliomas in humans
Fiano, V
Ghimenti, C
Schiffer, D
NEUROSCIENCE LETTERS, 2003, 347 (02) : 111 - 115
[40] Cyclin and cyclin-dependent kinase expression in the remnant glomerulus
Shankland, SJ
Hamel, P
Scholey, JW
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1997, 8 (03): : 368 - 375

← 1 2 3 4 5 →